Abstracts and bio's

Mondher Toumi is M.D., M.Sc. in Biological Sciences and Ph.D. in Economic Sciences.

After working as Research Manager (1981-1993) in the laboratory of pharmacology at the University of Marseille, he joined the Public Health Department (1993-1995). From 1995 to 2008, he worked in the industry R&D, and in 2000 was appointed Global Vice President at Lundbeck A/S ; a pharmaceutical company specialized in CNS. Here he was in charge of economics, pricing, market access, epidemiology, risk management, public affairs and competitive intelligence.

In February 2009 he was appointed Professor at Lyon I University in the Department of Decision Sciences and Health Policies. The same year, he was appointed Director of the Chair of Public Health and Market Access. He established and he conducts the first European University Diploma of Market Access (EMAUD) in Paris, France. Further, he recently created the Market Access Society to promote education, research and scientific activities around market access, public health and medico-economic assessment. Since 2009, he also chairs the Annual Market Access Day, a purely academic event sponsored by EMAUD that has become a reference event in the area. In addition to contributing as reviewer on several journals, he is Chief Editor at an online Journal of Market Access and Health Policy. Furthermore, he has been Co-Chair of the Research Review Committee of the European International Society of Pharmacology and Outcomes Research (ISPOR) in 2012 / 2013.

His research area focuses on modelling decision-making and international healthcare policy comparisons.

Apart from these academic duties, Mondher Toumi founded in 2008 Creativ-Ceutical, an international consulting firm dedicated to support health industries and authorities in strategic decision-making; and Marco Polo Pharmaceuticals, a company engaged in repositioning in the field of CNS drugs.

Amongst his current professional and administrative responsibilities, he serves as Vice-President of the French Society of Health Economics (SFES), President of the International Society for Systems Sciences in Health Care (ISSSHC), and Advisor of the Director of ITC BAS RAS (Innovation Technology Center BioActive Substances Russian Academy of Science).

He has more than 100 scientific publications and oral communications, and has contributed to numerous books.